SEC Filing Summary
Filing identity: The supplied filing is FTAC Emerald Acquisition Corp.’s Form 10-K, not a filing for Fold Holdings, Inc. It covers the fiscal year ended December 31, 2022; the financial statements were audited and the report was signed March 29, 2023.
Business context and reporting period
FTAC Emerald was a SPAC with no operating business or operating revenue at year-end. Its stated focus was on potential acquisitions in ESG-related sectors, although it could pursue other industries. The filing reports that a non-binding letter of intent was signed March 16, 2023; this occurred after the reporting period.
Financial performance, cash flow and liquidity
- Revenue and margins: No operating revenue; margins are not meaningful for this pre-combination SPAC.
- Profit: 2022 net income was $1.12 million, versus a $99,988 net loss from inception through December 31, 2021. 2022 results included $3.62 million of trust-account interest, $1.78 million of operating and formation costs, and $726,410 of income-tax provision.
- Cash flow: Operating cash outflow was $1.70 million; investing cash outflow was $28.43 million, primarily reflecting trust deposits net of tax withdrawals; financing cash inflow was $28.98 million. Cash outside the trust fell to $72,753 from $1.23 million.
- Liquidity and assets: Year-end trust investments were $254.25 million, compared with $222.20 million in 2021. Working capital was $203,453. The stated redemption value was approximately $10.21 per public share.
- Debt and obligations: No working-capital loans were outstanding at year-end. Liabilities totaled $10.35 million, including $8.70 million of deferred underwriting discount payable only upon a business combination. The company also paid $360,000 in 2022 for sponsor-provided administrative services.
- Equity presentation: Stockholders’ deficit was $8.50 million; redeemable Class A shares were presented as temporary equity.
Changes versus the prior comparable period
The 2021 comparison covers only the period from the company’s February 2021 inception through year-end, rather than a full year. In 2022, the partial over-allotment added 2,869,342 public units and 86,081 private placement units. Trust investments increased, while cash outside the trust declined. The company moved from a small inception-period loss to net income, primarily because of higher interest earned on trust assets.
Outlook, risks and unusual items
- After the March 2023 letter of intent, the company’s deadline to complete a business combination was extended to September 20, 2023. The filing does not identify the proposed target or provide transaction terms.
- Management and the auditor cited substantial doubt about the company’s ability to continue as a going concern if it cannot complete a business combination by the deadline. The financial statements include no liquidation adjustments.
- After year-end, the sponsor agreed to provide up to $1.5 million under a non-interest-bearing note; the company had drawn $350,000 by January 13 and an additional $250,000 by February 24, 2023. The note is due upon a business combination; trust funds cannot repay it.
- Key risks include failure to complete a transaction before the deadline, limited outside-trust cash, redemptions reducing deal funding, competition for targets, sponsor and management conflicts, dilution, and potential claims against trust assets. The sponsor’s trust indemnity is not assured by verified available assets.
- Redemptions or repurchases after December 31, 2022 may be subject to the federal 1% excise tax, potentially reducing cash available for a transaction.
Important facts for investors to verify
- Confirm the intended issuer: this filing is for FTAC Emerald Acquisition Corp., not Fold Holdings, Inc.
- Verify the status, target, terms, financing conditions and outcome of the March 16, 2023 non-binding letter of intent.
- Check subsequent filings for the September 20, 2023 deadline, any extensions, transaction closing or liquidation.
- Confirm subsequent sponsor-note borrowings, repayment terms, and the company’s remaining cash outside the trust.
- Review redemption levels, trust-account balance, deferred underwriting and advisory fees, and any applicable excise-tax effects.
- Assess dilution and conflicts tied to founder shares, warrants, sponsor economics, related-party fees and management obligations to other entities.